Cargando…
Host and Viral Factors in Respiratory Syncytial Virus Infection
Respiratory syncytial virus (RSV) is a major worldwide pathogen for which there is still no effective vaccine or antiviral treatment available, and immunoprophylaxis with RSV-specific antibodies (e.g., palivizumab) is used in limited clinical settings. In this review, we discuss virus–host interacti...
Autores principales: | Mastrangelo, Peter, Hegele, Richard G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100662/ https://www.ncbi.nlm.nih.gov/pubmed/32226653 http://dx.doi.org/10.1007/s40124-013-0019-3 |
Ejemplares similares
-
Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK
por: Taylor, Sylvia, et al.
Publicado: (2016) -
Respiratory syncytial virus co-opts host mitochondrial function to favour infectious virus production
por: Hu, MengJie, et al.
Publicado: (2019) -
Emergency Department Septic Screening in Respiratory Syncytial Virus (RSV) and Non-RSV Bronchiolitis
por: Chee, Chris, et al.
Publicado: (2010) -
Respiratory syncytial virus: a systematic scientometric analysis of the global publication output and the gender distribution of publishing authors
por: Brüggmann, Dörthe, et al.
Publicado: (2017) -
A morphological transformation in respiratory syncytial virus leads to enhanced complement deposition
por: Kuppan, Jessica P, et al.
Publicado: (2021)